Details of the Drug

General Information of Drug (ID: DMGN1RB)

Drug Name

Epstein Barr-based gene therapy

Synonyms

Epstein Barr-based gene therapy (intradermal, cancer); EBV EBNA1/LMP2 gene therapy vaccine (intradermal, cancer), University of Birmingham; Epstein Barr-based gene therapy (intradermal, cancer), University of Birmingham

Indication

Disease Entry	ICD 11	Status	REF
Solid tumour/cancer	2A00-2F9Z	Phase 1	[1]
------------------------------------------------------------------------------------

Cross-matching ID

TTD ID: D05IEN

References

1	A recombinant modified vaccinia ankara vaccine encoding Epstein-Barr Virus (EBV) target antigens: a phase I trial in UK patients with EBV-positive cancer. Clin Cancer Res. 2014 Oct 1;20(19):5009-22.